Dysregulated RUNX2 signaling contributes not only to pathologies in skeletogenesis such as cleidocranial dysplasia, osteoporosis, and OA, but also vascular calcification and cancer progression and metastasis. The gene discussed is RUNX2; the disease is osteoporosis.